Published in Mol Cell Endocrinol on April 04, 1997
Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 1.15
PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis. J Clin Invest (2007) 1.00
Nuclear factor-kappaB regulates estrogen receptor-alpha transcription in the human heart. J Biol Chem (2009) 0.82
Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst (1991) 2.16
Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc (1992) 1.82
Isolation and characterisation of the Xenopus laevis albumin genes: loss of 74K albumin gene sequences by library amplification. Nucleic Acids Res (1982) 1.80
Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem (1990) 1.57
Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer (1990) 1.52
Cathepsin D and breast cancer. Eur J Cancer (1996) 1.47
NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol (1990) 1.44
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer (1991) 1.43
Mitogenic activity of procathepsin D purified from conditioned medium of breast-cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer (1994) 1.41
Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol (1997) 1.39
Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res (1987) 1.31
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. J Biol Chem (1984) 1.31
Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol (1991) 1.28
Drug interactions and multiple drug administration. Clin Pharmacol Ther (1977) 1.28
Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res (1986) 1.27
In contrast to other Xenopus genes the estrogen-inducible vitellogenin genes are expressed when totally methylated. Cell (1983) 1.26
Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem (2000) 1.24
The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut (2000) 1.22
Vitellogenin genes A1 and B1 are linked in the Xenopus laevis genome. Proc Natl Acad Sci U S A (1982) 1.20
Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer (1991) 1.20
Structure of a human retroviral sequence related to mouse mammary tumor virus. J Virol (1986) 1.19
The human genome contains multiple sequences of varying homology to mouse mammary tumour virus DNA. Gene (1984) 1.19
Do benefits and barriers differ by stage of adoption for colorectal cancer screening? Health Educ Res (2004) 1.17
Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J (1997) 1.17
Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer (1995) 1.17
Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J Biol Chem (1988) 1.16
Expression of human sequences related to those of mouse mammary tumor virus. J Virol (1988) 1.16
Prognostic value of cathepsin D in breast cancer. Br J Cancer (1999) 1.13
Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J Biol Chem (1987) 1.13
Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer (1990) 1.09
Measurement of oestrogen receptor mRNA levels in human breast tumours. Br J Cancer (1988) 1.08
Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects. J Pathol (1998) 1.08
Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J Steroid Biochem (1989) 1.07
High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J Mol Biol (1997) 1.06
The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS. J Pathol (1999) 1.05
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. Eur J Cancer (1993) 1.04
Mouse mammary tumour virus related sequences are present in human DNA. Nucleic Acids Res (1983) 1.04
Trefoil proteins: their role in normal and malignant cells. J Pathol (1997) 1.03
Prognostic significance of cathepsin-D in patients with breast cancer. Br J Cancer (1993) 1.02
Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer (1992) 1.00
Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol (1994) 0.99
Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br J Cancer (1989) 0.98
Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. J Steroid Biochem (1989) 0.97
Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol Endocrinol (1999) 0.94
Clinical research in the elderly: ethical and methodological considerations. Drug Intell Clin Pharm (1987) 0.93
Quantitation of DNase I sensitivity in Xenopus chromatin containing active and inactive globin, albumin and vitellogenin genes. Nucleic Acids Res (1981) 0.93
The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa. Cell Mol Life Sci (2004) 0.93
Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers. Clin Cancer Res (1999) 0.93
NCL-5D3: a new monoclonal antibody recognizing low molecular weight cytokeratins effective for immunohistochemistry using fixed paraffin-embedded tissue. J Pathol (1987) 0.93
Symptom prevalence in the elderly. An evaluation of age, sex, disease, and medication use. J Am Geriatr Soc (1986) 0.91
Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells. J Steroid Biochem (1989) 0.90
Changing patterns of therapeutic agents in the elderly: a ten-year overview. Age Ageing (1991) 0.89
Estrogen dramatically decreases albumin mRNA levels and albumin synthesis in Xenopus laevis liver. J Biol Chem (1982) 0.88
A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol (1991) 0.88
int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc. Int J Cancer (1993) 0.87
c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma. J Hepatol (1992) 0.87
Headache in the elderly: an evaluation of risk factors. Headache (1987) 0.87
Prescribed and nonprescribed drug use in an ambulatory elderly population. South Med J (1982) 0.86
Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. Biochem J (1995) 0.86
Changing patterns of psychotropic drug use in the elderly: a five-year update. DICP (1989) 0.85
Nuclear binding of the oestrogen receptor of neonatal rat brain after injection of oestrogens and androgens; localization and sex differences. Brain Res (1977) 0.85
Structure and evolution of the Xenopus laevis albumin genes. J Mol Biol (1983) 0.84
Dermatologic adverse drug reactions in hospitalized patients. Am J Hosp Pharm (1979) 0.84
Oestrogen receptor levels and vitellogenin synthesis during development of Xenopus laevis. Nature (1981) 0.84
The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut (2000) 0.83